Associated Papers
A covalent fragment-based strategy targeting a novel cysteine to inhibit activity of mutant EGFR kinase.
Kuki N et al.
Rsc Medicinal Chemistry, 2023
Structural Basis of AZD9291 Selectivity for EGFR T790M.
Yan XE et al.
Journal of Medicinal Chemistry, 2020
Discovery of selective and noncovalent diaminopyrimidine-based inhibitors of epidermal growth factor receptor containing the T790M resistance mutation.
Hanan EJ et al.
Journal of Medicinal Chemistry, 2014
25383627 (PubMed )
Supplement: jm501578n_si_001.pdf
Select a paper to view details